Category: From Newswise – Addiction

During the COVID-19 pandemic, Johns Hopkins Medicine Media Relations is focused on disseminating current, accurate and useful information to the public via the media. As part of that effort, we are distributing our “COVID-19 Tip Sheet: Story Ideas from Johns Hopkins” every other Wednesday.

Researchers at Penn Medicine used machine learning-aided analysis to uncover top positive and negative themes in patient Yelp reviews of substance use treatment facilities

The coronavirus pandemic has led to several temporary regulatory relaxations and policy innovations in treatment for opioid use disorder aimed at making it easier for those seeking care to access treatment without risking in-person interactions. The Foundation for Opioid Response Efforts (FORE) today announced it is providing grants totaling $1.3 million to six organizations to assess the impact of these temporary measures and inform future policies to improve access and promote equity for the treatment of opioid use disorder.

Risky drinking often co-occurs with maladaptive eating in young adults, according to a study reported in Alcoholism: Clinical and Experimental Research. While previous research had suggested a link between heavy alcohol use and obesity-related factors in college students, the latest study aimed to identify specific profiles of problematic drinking, food addiction, and obesity within a more diverse sample of community-dwelling young people. The researchers also explored shared theoretical risk factors for heavy drinking and overeating, and how these differ across the profiles. Calorie-dense food and alcohol both require little effort to obtain and consume, and each generates immediate and potent experiences of reward in the brain. According to ‘reinforcer pathology’ theory, people who place a high value (‘demand’) on unhealthy items, and who also favor small immediate rewards (such as food and alcohol) over larger delayed rewards (such as health), are at highest risk for overconsumption

The legalization of cannabis and the arrival of nonmedical fentanyl are fundamentally changing drug markets in North America.

A new study published Tuesday 10 March, No Smoking Day, from King’s College London highlights the ‘clear benefit’ of using e-cigarettes daily in order to quit smoking, and supports their effectiveness when compared to other methods of quitting, including nicotine replacement therapy or medication.

A new study shows that providing a non-acute care space after hospital discharge for patients with COVID-19 who are experiencing homelessness helped reduce hospitalizations and keep inpatient beds available for those requiring acute care.

The first-wave COVID-19 lockdown in Barcelona, Spain, has been linked to increased drinking among people recovering from alcohol use disorder (AUD), as reported in Alcoholism: Clinical and Experimental Research. Pandemic-associated stress has already been associated with increased drinking in the general population, but few studies have examined the impact among people with a clinical diagnosis of AUD, who may be particularly susceptible to using alcohol as a coping mechanism. Additionally, almost all COVID-19 studies to date have been based on self-reported alcohol use, which does not always provide an accurate measure, particularly among heavy drinkers and those with AUD. In the latest study, researchers used the results of urine alcohol tests to assess changes in alcohol consumption among people with AUD before and after the first-wave lockdown. Although the lockdown in Spain was one of the strictest in the world, with residents allowed to leave homes for basic needs only, alcohol r

Dr. Carlos Pato and Dr. Michele Pato to Oversee Behavioral Health, Addictions and Genomic Psychiatry Research at Rutgers Biomedical and Health Sciences

Although the prevalence of opioid use among Black people is comparatively low, the rate of opioid deaths has increased the sharpest and fastest among that population in recent years, according to an article in the March/April issue of Harvard Review of Psychiatry. The journal is published in the Lippincott portfolio by Wolters Kluwer.